Company · Stevenage
Stevenage Bioscience Catalyst
Other business support service activities n.e.c.
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Stevenage Bioscience Catalyst. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 13
- Graham Paul Rivers 2023-2026 View profile
- James Russell Wheatcroft 2020-2023 View profile
- Clare Elizabeth Terlouw 2019-2023 View profile
- Dr Sally Ann Forsyth 2018-2026 View profile
- Iain Stuart Ward 2017-2018 View profile
- Daniel Nelki 2016-2017 View profile
- Dave Allen 2016-2020 View profile
- Dr Veronique Anne Bouchet 2012-2022 View profile
- Ian Michael Tomlinson 2011-2020 View profile
- Martino Picardo 2011-2017 View profile
- Dr Timothy Rink 2010-2012 View profile
- John Cooper 2010-2016 View profile
- Dr Allan Baxter 2010-2015 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Other business support service activities n.e.c.
- Incorporated
- 19/03/2010
- Registered office
- Stevenage
- Previous names
- Stevenage Bioscience Park (until 02/08/2010)
Ownership
Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Glaxosmithkline Research & Development Limited
25-50% voting · notified 2016-04-06 - The Wellcome Trust Limited
25-50% voting · notified 2016-04-06
Group
- Stevenage Bioscience Catalyst
is controlled by Glaxosmithkline Research & Development Limited
Evidence
active 25-50% voting · notified 2016-04-06 · source: Companies House PSC register - Glaxosmithkline Research & Development Limited
is controlled by Glaxo Group Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxo Group Limited
is controlled by Glaxosmithkline Finance PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxosmithkline Finance PLC
is controlled by Glaxosmithkline Holdings Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxosmithkline Holdings Limited
is controlled by GSK PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by GSK PLC.
86 other companies in this group
- Smithkline Beecham Legacy H Limited
- Smithkline Beecham Overseas Limited
- GSK LP Limited
- Setfirst Holdings Limited
- Glaxo Laboratories Limited
- Smithkline Beecham Senior Executive Pension Plan Trustee Limited
- Glaxosmithkline IHC Limited
- Smithkline Beecham Marketing and Technical Services Limited
- Stiefel Laboratories (Maidenhead) Limited
- GSK Equity Investments NO2 Limited
- Viiv Healthcare Finance Limited
- Charles Midgley Limited
- GSK Finance (NO 2) Limited
- Glaxosmithkline Caribbean Limited
- Burroughs Wellcome International Limited
- Smithkline Beecham Pension Trustees Limited
- Stiefel Laboratories Limited
- Glaxosmithkline Mercury Limited
- Setfirst Limited
- Dealcyber Limited
- GSK Finance (NO.3) Limited
- Viiv Healthcare UK (NO.5) Limited
- Viiv Healthcare Finance 2 Limited
- Wellcome Consumer Healthcare Limited
- Glaxo Wellcome UK Limited
- Glaxosmithkline Intellectual Property Management Limited
- Glaxosmithkline Intellectual Property Limited
- Mixis Genetics Limited
- Glaxo Group Limited
- Allen & Hanburys Limited
- Glaxosmithkline Intellectual Property Holdings Limited
- Smithkline Beecham (Export) Limited
- Glaxosmithkline Intellectual Property Development Limited
- Viiv Healthcare Trading Services UK Limited
- Viiv Healthcare Finance 1 Limited
- Clarges Pharmaceuticals Limited
- Glaxo Trustees Limited
- Glaxosmithkline International Limited
- Glaxochem (UK) Unlimited
- Viiv Healthcare Limited
- Tres Cantos Open LAB Foundation
- Viiv Healthcare UK (NO.3) Limited
- Glaxosmithkline Intellectual Property (NO.5) Limited
- Eskaylab Limited
- Glaxosmithkline Intellectual Property (NO.2) Limited
- Viiv Healthcare UK (NO.4) Limited
- Cellzome Limited
- Smithkline Beecham (SWG) Limited
- Smith Kline & French Laboratories Limited
- Glaxosmithkline Export Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Financials
- Net assets
- £4,302,693
- Total assets
- £18,590,836
- Cash
- £1,544,048
- Employees
- 17
- Turnover
- £4,091,025
- Profit/loss
- -£683,178
Figures from accounts filed at Companies House (iXBRL), period ending 2025-03-31. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
4 directors on the board
- Professor Ann Jacqueline Hunter Director · appointed 2020
- Dr Uday Prabhakar Phadke Director · appointed 2023
- Dr Lynn Drummond Director · appointed 2023
- Jonathan Alexander Green Director · appointed 2019
Directors past 6 years
- Professor Ann Jacqueline Hunter Director · appointed 2020
- Jonathan Alexander Green Director · appointed 2019
First-time vs portfolio directors
Portfolio (4)
- Professor Ann Jacqueline Hunter Director · appointed 2020
- Dr Uday Prabhakar Phadke Director · appointed 2023
- Dr Lynn Drummond Director · appointed 2023
- Jonathan Alexander Green Director · appointed 2019
Also govern a charity
Left in the last 12 months
- Graham Paul Rivers Director · appointed 2023 · resigned 2026
- Dr Sally Ann Forsyth Director · appointed 2018 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 07196230
- Status
- Active
- Type
- PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)
- Accounts next due
- 31/12/2026
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data